![Marcus Schindler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcus Schindler
Inga fler pågående positioner
Profil
Marcus Schindler formerly worked at Innate Pharma SA, as Member-Supervisory Board from 2018 to 2021, Novo Nordisk A, as Chief Scientific Officer & Executive VP-Research from 2021 to 2025, Prosidion Ltd., as Head-Research from 2009 to 2012, and AstraZeneca A, as Vice President & Head-Cardiovascular from 2013 to 2017.
Dr. Schindler received his doctorate degree in 1997 from the University of Cambridge and graduate degree in 1994 from the University of Gottingen.
Senaste nyheterna om Marcus Schindler
Tidigare kända positioner av Marcus Schindler
| Företag | Position | Slut |
|---|---|---|
| NOVO NORDISK A/S | Teknisk/Vetenskaplig/F&U Direktör | 2025-08-07 |
| INNATE PHARMA | Direktör/Styrelseledamot | 2021-05-28 |
AstraZeneca A/S (Denmark)
 AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Företagsledare/Principal | 2017-12-01 |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases | Teknisk/Vetenskaplig/F&U Direktör | 2012-01-01 |
Marcus Schindlers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases | Health Technology |
University of Gottingen
 University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
